PHGE (STOCKS)
BiomX Inc.
$0.547800
+0.011600 (+2.16%)
Prev close: $0.536200
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Michael Oster
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $6.03M
- Employees
- 57
- P/E (TTM)
- -0.02
- P/B (TTM)
- -0.22
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2025 (Q4)
|
$-8.17 | $-4.70 | -3.4678 | -73.75% |
|
Sep 2025 (Q3)
|
$-5.51 | $-6.20 | +0.6916 | +11.15% |
|
Jun 2025 (Q2)
|
$-3.61 | $-6.30 | +2.6885 | +42.68% |
|
Mar 2025 (Q1)
|
$-6.27 | $-6.98 | +0.7068 | +10.13% |
Financial Statements
| Operating Income/Loss | -$35.01M |
| Income/Loss From Continuing Operations After Tax | -$47.68M |
| Income/Loss From Continuing Operations Before Tax | -$47.68M |
| Net Income/Loss | -$45.82M |
| Net Income/Loss Attributable To Noncontrolling Interest | $1.86M |
| Net Income/Loss Attributable To Parent | -$47.68M |
| Net Income/Loss Available To Common Stockholders, Basic | -$36.71M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | -$10.97M |
| Preferred Stock Dividends And Other Adjustments | -$10.97M |
| Basic Earnings Per Share | $23.30 |
| Diluted Earnings Per Share | $23.30 |
| Basic Average Shares | 3,018,891 |
| Assets | $3.25M |
| Current Assets | $3.04M |
| Noncurrent Assets | $208.00K |
| Liabilities | $4.13M |
| Current Liabilities | $2.45M |
| Noncurrent Liabilities | $1.69M |
| Equity | -$881.00K |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$881.00K |
| Liabilities And Equity | $3.25M |
| Net Cash Flow From Operating Activities | -$23.09M |
| Net Cash Flow From Operating Activities, Continuing | -$23.09M |
| Net Cash Flow From Investing Activities | -$939.00K |
| Net Cash Flow From Investing Activities, Continuing | -$939.00K |
| Net Cash Flow From Financing Activities | $3.90M |
| Net Cash Flow From Financing Activities, Continuing | $3.90M |
| Net Cash Flow | -$20.06M |
| Net Cash Flow, Continuing | -$20.13M |
| Comprehensive Income/Loss | -$45.82M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$45.82M |
| Other Comprehensive Income/Loss | $0.00 |